107 related articles for article (PubMed ID: 1949170)
1. The protective effects of the thromboxane synthetase inhibitor Dazmegrel on nephrotoxicity in cyclosporine-treated rats.
Gladue RP; Newborg MF
Transplantation; 1991 Nov; 52(5):837-41. PubMed ID: 1949170
[TBL] [Abstract][Full Text] [Related]
2. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity.
Schnabel FR; Wait RB; Kahng KU
Transplantation; 1991 Mar; 51(3):686-9. PubMed ID: 2006526
[TBL] [Abstract][Full Text] [Related]
3. The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition.
Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
Biochem Pharmacol; 1993 Mar; 45(6):1351-4. PubMed ID: 8466554
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
dos Santos OF; Boim MA; Barros EJ; Pirotzky E; Braquet P; Schor N
Lipids; 1991 Dec; 26(12):1320-3. PubMed ID: 1819724
[TBL] [Abstract][Full Text] [Related]
5. Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
Biochem Pharmacol; 1990 Nov; 40(10):2323-9. PubMed ID: 2244933
[TBL] [Abstract][Full Text] [Related]
6. Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity.
Smith SR; Kubacki VB; Rakhit A; Martin LL; Schaffer AV; Jasani MK; Hefty DJ; Johnston T; Cannon C; Bennett WM
Transplantation; 1993 Dec; 56(6):1422-6. PubMed ID: 8279014
[TBL] [Abstract][Full Text] [Related]
7. Modulation of experimental cyclosporine nephrotoxicity by inhibition of thromboxane synthesis.
Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
Transplantation; 1990 Oct; 50(4):558-63. PubMed ID: 2219273
[TBL] [Abstract][Full Text] [Related]
8. Reduction of chronic ciclosporin nephrotoxicity by thromboxane synthase inhibition with OKY-046.
Kim YJ; Park YH; Moon HK
Kidney Blood Press Res; 1997; 20(1):38-43. PubMed ID: 9192909
[TBL] [Abstract][Full Text] [Related]
9. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
10. Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat.
Blume C; Heise G; Hess A; Waldner C; Grabensee B; Schroer K; Heering P
Nephron Exp Nephrol; 2005; 100(2):e104-12. PubMed ID: 15855806
[TBL] [Abstract][Full Text] [Related]
11. Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity.
Pere AK; Lindgren L; Tuomainen P; Krogerus L; Rauhala P; Laakso J; Karppanen H; Vapaatalo H; Ahonen J; Mervaala EM
Kidney Int; 2000 Dec; 58(6):2462-72. PubMed ID: 11115079
[TBL] [Abstract][Full Text] [Related]
12. Spirulina attenuates cyclosporine-induced nephrotoxicity in rats.
Khan M; Shobha JC; Mohan IK; Rao Naidu MU; Prayag A; Kutala VK
J Appl Toxicol; 2006; 26(5):444-51. PubMed ID: 16858688
[TBL] [Abstract][Full Text] [Related]
13. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity.
Coffman TM; Carr DR; Yarger WE; Klotman PE
Transplantation; 1987 Feb; 43(2):282-5. PubMed ID: 3810836
[TBL] [Abstract][Full Text] [Related]
14. A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathy.
Masumura H; Kunitada S; Irie K; Ashida S; Abe Y
Eur J Pharmacol; 1992 Jan; 210(2):163-72. PubMed ID: 1350991
[TBL] [Abstract][Full Text] [Related]
15. Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine.
Elzinga L; Kelley VE; Houghton DC; Bennett WM
Transplantation; 1987 Feb; 43(2):271-4. PubMed ID: 3810835
[TBL] [Abstract][Full Text] [Related]
16. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
Lianos EA; Andres GA; Dunn MJ
J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
[TBL] [Abstract][Full Text] [Related]
17. Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity.
Smith SR; Creech EA; Schaffer AV; Martin LL; Rakhit A; Douglas FL; Klotman PE; Coffman TM
Kidney Int; 1992 Jan; 41(1):199-205. PubMed ID: 1593856
[TBL] [Abstract][Full Text] [Related]
18. Prevention of experimental cyclosporine nephrotoxicity by dietary supplementation with LSL 90202, a lysine salt of eicosapentaenoic acid. Role of thromboxane and prostacyclin in renal tissue.
Torras J; Valles J; Sanchez J; Sabate I; Seron D; Carrera M; Castelao AM; Herrero I; Puig-Parellada P; Alsina J
Nephron; 1994; 67(1):66-72. PubMed ID: 8052370
[TBL] [Abstract][Full Text] [Related]
19. A pilot study to assess the ability of an orally available selective thromboxane synthase inhibitor to improve renal function in cyclosporine-treated renal transplant recipients.
Weir MR; Klassen DK; Burdick JF
J Am Soc Nephrol; 1992 Feb; 2(8):1285-90. PubMed ID: 1627753
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent cyclosporine A-induced nephrotoxicity in rats.
Yamauchi H; Kobayashi E; Sugimoto K; Tsuruoka S; Yabana M; Ishii M; Fujimura A
Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):435-40. PubMed ID: 9673819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
